Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review

Expert Review of Molecular Diagnostics

Volumn 11, Issue 6, 2011, Pages 605-616

  Haug, Ulrike ^a   Knudsen, Amy B ^b   Brenner, Hermann ^a   Kuntz, Karen M ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

colorectal cancer; colorectal neoplasia; fecal occult blood testing; screening

Indexed keywords

ADVANCED CANCER; CANCER SCREENING; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE ANATOMY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOCHEMISTRY; MEDLINE; OCCULT BLOOD; OCCULT BLOOD TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUMOR VOLUME;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HEMOGLOBINS; HUMANS; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79960239011     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.41     Document Type: Review

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010)
2. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 343, 1603-1607 (2000) (Pubitemid 32162983)
3. Atkin WS, Edwards R, Kralj-Hans I et al.; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375, 1624-1633 (2010)
4. Mandel J, Church T, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 328, 1365-1371 (1993) (Pubitemid 23131388)
5. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348, 1472-1477 (1996) (Pubitemid 26400242)
6. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50, 29-32 (2002) (Pubitemid 34028299)
7. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann. Intern. Med. 154, 22-30 (2011)
8. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J. Natl Cancer Inst. 102, 89-95 2010)
9. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M. Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case-control study. Cancer Epidemiol. Biomarkers Prev. 16, 494-499 (2007) (Pubitemid 46548652)
10. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer: a population-based, case-control study. Ann. Intern. Med. 150, 1-8 (2009)
11. Soetikno RM, Kaltenbach T, Rouse RV et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299, 1027-1035 (2008) (Pubitemid 351347059)
12. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med. 113, 779-788 (1990) (Pubitemid 20369667)
13. Azzoni C, Bottarelli L, Campanini N et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int. J. Colorectal Dis. 22, 115-126 (2007) (Pubitemid 44964014)
14. Rozen P, Levi Z, Hazazi R et al. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment. Pharmacol. Ther. 29, 906-917 (2009)
15. Ciatto S, Martinelli F, Castiglione G et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br. J. Cancer 96, 218-221 (2007) (Pubitemid 46160624)
16. Blatt LJ. Polyps of the colon and rectum: incidence and distribution. Dis. Colon Rectum 4, 277-282 (1961)
17. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer 42, 2839-2848 (1978) (Pubitemid 9107564)
18. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 43, 1847-1857 (1979) (Pubitemid 9203736)
19. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 23, 835-842 (1982) (Pubitemid 12018511)
20. Rockey DC. Occult and obscure gastrointestinal bleeding: causes and clinical management. Nat. Rev. Gastroenterol. Hepatol. 7, 265-279 (2010)
21. Burch JA, Soares-Weiser K, St John DJ et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J. Med. Screen. 14, 132-137 (2007) (Pubitemid 47511122)
22. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am. J. Gastroenterol. 101, 343-350 (2006) (Pubitemid 43381678)
23. Heresbach D, Barrioz T, Lapalus MG et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 40, 284-290 (2008) (Pubitemid 351524375)
24. Lieberman DA, Weiss DG; for the Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345, 555-560 (2001) (Pubitemid 32772096)
25. Collins JF, Lieberman DA, Durbin TE, Weiss DG; for the Veterans Affairs Cooperative Study Group 380. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann. Intern. Med. 142, 81-85 (2005)
26. Ahlquist DA, Sargent DJ, Loprinzi CL et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann. Intern. Med. 149, 441-450 (2008)
27. Graser A, Stieber P, Nagel D et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy, and fecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 58, 241-248 (2009)
28. Park DI, Ryu S, Kim YH et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am. J. Gastroenterol. 105, 2017-2025
29. Nakama H, Zhang B, Fattah AA, Kamijo N, Zhang X. Characteristics of colorectal cancer that produce positive immunochemical occult blood test results on stool obtained by digital rectal examination. Can. J. Gastroenterol. 15, 227-230 (2001) (Pubitemid 32496344)
30. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129, 422-428 (2005) (Pubitemid 41096630)
31. Nakazato M, Yamano HO, Matsushita HO et al. Immunologic fecal occult blood test for colorectal cancer screening. Jpn Med. Assoc. J. 49, 203-207 (2006) (Pubitemid 44209592)
32. Morikawa T, Kato J, Yamaji Y et al. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am. J. Gastroenterol. 102, 2259-2264 (2007) (Pubitemid 47493843)
33. Levi Z, Rozen P, Hazazi R et al. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am. J. Gastroenterol. 104, 933-938 (2009)
34. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Cochrane diagnostics test accuracy working group. Ann. Intern. Med. 149, 889-897 (2008)
35. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann. Intern. Med. 149, 659-669 (2008)
36. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 137, 96-104 (2002) (Pubitemid 34779153)
37. Homepage Centre for Reviews and Dissemination www.york.ac.uk/inst/crd/ CRD-Reports/crdreport36.pdf
38. National Cancer Institute Visuals Online